Heart Failure Flashcards

1
Q

What are the features of chronic heart failure?

A
dyspnoea
cough
orthopnoea
paroxysmal nocturnal dyspnoea
wheeze ('cardiac wheeze')
bibasal crackles on examination
signs of right-sided heart failure: raised JVP, ankle oedema and hepatomegaly
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is specific about chronic heart failure cough?

A

may be worse at night and associated with pink/frothy sputum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

People with heart failure sometimes lose weight

A
true
weight loss ('cardiac cachexia'): occurs in up to 15% of patients. Remember this may be hidden by weight gained secondary to oedema
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the first line investigation for suspected chronic heart failure?

A

N-terminal pro-B-type natriuretic peptide (NT‑proBNP) blood test first-line

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

If NT‑proBNP results are ‘high’ what should you do?

A

arrange specialist assessment (including transthoracic echocardiography) within 2 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

If NT‑proBNP results are ‘raised’ what should you do?

A

arrange specialist assessment (including transthoracic echocardiography) echocardiogram within 6 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is BNP?

A

B-type natriuretic peptide (BNP) is a hormone produced mainly by the left ventricular myocardium in response to strain. Very high levels are associated with a poor prognosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are high, raised and normal levels of NTproBNP?

A

> 2000 pg/ml (236 pmol/litre)
400-2000 pg/ml (47-236 pmol/litre)
< 400 pg/ml (47 pmol/litre)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What factors Increase BNP levels?

A
Left ventricular hypertrophy
Ischaemia
Tachycardia
Right ventricular overload
Hypoxaemia (including pulmonary embolism)
GFR < 60 ml/min
Sepsis
COPD
Diabetes
Age > 70
Liver cirrhosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What factors decrease BNP levels?

A
Obesity
Diuretics
ACE inhibitors
Beta-blockers
Angiotensin 2 receptor blockers
Aldosterone antagonists
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are high, raised and normal levels of BNP?

A

> 400 pg/ml (116 pmol/litre)
100-400 pg/ml (29-116 pmol/litre)
< 100 pg/ml (29 pmol/litre)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What classification is widely used to classify the severity of heart failure?

A

New York Heart Association (NYHA)

4 classes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is NYHA Class I?

A

no symptoms

no limitation: ordinary physical exercise does not cause undue fatigue, dyspnoea or palpitations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is NYHA Class II?

A

mild symptoms
slight limitation of physical activity: comfortable at rest but ordinary activity results in fatigue, palpitations or dyspnoea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is NYHA Class III?

A

moderate symptoms

marked limitation of physical activity: comfortable at rest but less than ordinary activity results in symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is NYHA Class IV?

A

severe symptoms
unable to carry out any physical activity without discomfort: symptoms of heart failure are present even at rest with increased discomfort with any physical activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

first-line treatment for all patients is?

A

ACE-inhibitor and a beta-blocker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Which beta-blockers licensed to treat heart failure in the UK?

A

isoprolol, carvedilol, and nebivolol.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

ACE-inhibitors and beta-blockers have no effect on mortality in heart failure with what?

A

preserved ejection fraction

20
Q

Second-line treatment is?

A

aldosterone antagonist

spironolactone and eplerenone

21
Q

Which drugs in management of heart failure can cause hyperkalaemia?

A

both ACE inhibitors (which the patient is likely to already be on) and aldosterone antagonists both cause hyperkalaemia

22
Q

Which electrolyte should be monitored in management of heart failure?

A

Potassium

Hyperkalaemia

23
Q

Third line management is?

A
should be initiated by a specialist. 
Options include ivabradine
sacubitril-valsartan
hydralazine in combination with nitrate
digoxin 
cardiac resynchronisation therapy
24
Q

What is the criteria for prescribing Ivabridine?

A

sinus rhythm > 75/min and a left ventricular fraction < 35%

25
What is the criteria for prescribing sacubitril-valsartan?
left ventricular fraction < 35% is considered in heart failure with reduced ejection fraction who are symptomatic on ACE inhibitors or ARBs should be initiated following ACEi or ARB wash-out period
26
When is digoxin strongly indicated?
coexistent atrial fibrillation
27
Which drugs have not been proven to reduce mortality in patients with heart failure but may however improve symptoms?
Digoxin - inotropic properties | loop diuretics such as furosemide, but important role in managing fluid overload
28
When is hydralazine in combination with nitrate strongly indicated?
Afro-Caribbean patients
29
When is cardiac resynchronisation therapy strongly indicated?
widened QRS (e.g. left bundle branch block) complex on ECG
30
What vaccines should be offered to people with heart failure?
offer annual influenza vaccine offer one-off pneumococcal vaccine adults usually require just one dose but those with asplenia, splenic dysfunction or chronic kidney disease need a booster every 5 years
31
Acute heart failure (AHF) is life-threatening emergency
true HF is a term used to describe the sudden onset or worsening of the symptoms of heart failure. Thus it may present with or without a background history of pre-existing heart failure.
32
Decompensated acute HF is more common and presents with a background history of HF
true | 66-75%
33
At what age does acute heart failure usually present
after the age of 65-years
34
AHF is usually caused by what?
reduced cardiac output that results from a functional or structural abnormality.
35
What is De novo heart failure?
AHF without a past history of heart failure increased cardiac filling pressures and myocardial dysfunction usually as a result of ischaemia. This causes reduced cardiac output and therefore hypoperfusion. This, in turn can cause pulmonary oedema.
36
What are the common and uncommon causes of de novo heart failure?
``` Common: ischaemia less common causes of de-novo AHF are: Viral myopathy Toxins Valve dysfunction ```
37
What are the most common precipitating causes of acute AHF are?
``` Acute coronary syndrome Hypertensive crisis Acute arrhythmia Valvular disease There is generally a history of pre-existing cardiomyopathy ```
38
What are the symptoms of AHFt?
Breathlessness Cyanosis Reduced exercise tolerance Tachycardia Oedema
39
What are the signs of AHFt?
``` Elevated jugular venous pressure Faitgue Displaced apex beat Chest signs: classically bibasal crackles but may also cause a wheeze S3-heart sound ```
40
Over 90% of patients with AHF have a normal or increased blood pressure
true
41
Why do blood tests for AHF?
to look for any underlying abnormality such as anaemia, abnormal electrolytes or infection.
42
What does CXR show in AHF?
pulmonary venous congestion, interstitial oedema and cardiomegaly
43
Why do blood echo for AHF?
this will identify pericardial effusion and cardiac tamponade
44
B-type natriuretic peptide is diagnostic of AHF
``` false raised levels (>100mg/litre) indicate myocardial damage and are supportive of the diagnosis. ```
45
How do you manage acute heart failure?
``` oxygen IV loop diuretics opiates vasodilators inotropic agents CPAP ultrafiltration mechanical circulatory assistance: e.g. intra-aortic balloon counterpulsation or ventricular assist devices ``` Consideration should be given to discontinuing beta-blockers in the short-term.